8
panel
FasterCures Advisory Councils Meeting (Invite only)
This meeting brings together the FasterCures Advisory Groups—including the Board, Business Counc
il, and Changemakers nonprofit advisory council—to discuss timely topics across the biomedical research ecosystem.
+ Read More
staff
Brenda Huneycutt, PhD
Brenda Huneycutt, PhD, is a senior director at the Milken Institute, where she directs the expans
ion of MI Health programmatic work internationally across all MI Health portfolios.
+ Read More
landing page
Research Partnership Maturity Model
FasterCures created the Research Partnership Maturity Model (RPMM) toolkit to enable patient organiz
ations that support or conduct research to 1) understand their assets and capab, Access the Model Visualization and Companion Guide
, Tools You Can Use
This collection of tools provides resources aligned to the RPMM domains, and examples that can support the growth of patient organizations hoping to build their capacity in
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
article
Mapping the Patient and Caregiver Journey for Cell and Gene Therapies
Introduction
Advances in cell and gene therapies are transforming how we treat or potentially cure
disease. Cell and gene therapies aim to address the underlying cause of genetic and acquired diseases.
+ Read More
article
Comment Letter: Advanced Research Projects Agency for Health (ARPA-H) Request for Information
Submitted electronically
The Honorable Diana DeGette
US House of Representatives
Washington, DC 205
15
The Honorable Fred Upton
US House of Representatives
Washington, DC 20515
+ Read More
article
Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health
Esther Krofah, executive vice president of Milken Institute Health, (pictured at left) with Emma Wal
msley, CEO of GSK, (right) at the 2024 Milken Institute Global Conference.
+ Read More
article
Comment Letter: Office of Management and Budget (OMB) – Practices for Advancing Equity and Support for Underserved Communities
Submitted electronically
To: The Honorable Shalanda Young, Acting Director, Office of Management an
d Budget
From: Richard Ditizio, President and Chief Operating Officer, Milken Institute
+ Read More